Once-daily udenafil 50mg compared with udenafil 200mg on-demand in diabetic men with erectile dysfunction
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2015
At a glance
- Drugs Udenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Dong-A Pharmaceutical
- 05 Oct 2012 Identifier DA8159-DDM-IV added and Dong A Pharmaceutical added as study supporter.
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
- 08 Dec 2011 Results presented at the 21st World Diabetes Congress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History